DE602004004674T2 - Verfahren zur herstellung von benzoxazolsulfonamidverbindungen und zwischenprodukten davon - Google Patents

Verfahren zur herstellung von benzoxazolsulfonamidverbindungen und zwischenprodukten davon Download PDF

Info

Publication number
DE602004004674T2
DE602004004674T2 DE602004004674T DE602004004674T DE602004004674T2 DE 602004004674 T2 DE602004004674 T2 DE 602004004674T2 DE 602004004674 T DE602004004674 T DE 602004004674T DE 602004004674 T DE602004004674 T DE 602004004674T DE 602004004674 T2 DE602004004674 T2 DE 602004004674T2
Authority
DE
Germany
Prior art keywords
alkyl
het
aryl
formula
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004004674T
Other languages
German (de)
English (en)
Other versions
DE602004004674D1 (de
Inventor
Herman Augustinus De Kock
Walter Ferdinand Maria Filliers
Wim Albert Alex Aelterman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen R&D Ireland ULC
Original Assignee
Tibotec Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharmaceuticals Ltd filed Critical Tibotec Pharmaceuticals Ltd
Publication of DE602004004674D1 publication Critical patent/DE602004004674D1/de
Application granted granted Critical
Publication of DE602004004674T2 publication Critical patent/DE602004004674T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602004004674T 2003-09-30 2004-09-30 Verfahren zur herstellung von benzoxazolsulfonamidverbindungen und zwischenprodukten davon Expired - Lifetime DE602004004674T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP03103630 2003-09-30
EP03103630 2003-09-30
US50799603P 2003-10-02 2003-10-02
US507996P 2003-10-02
PCT/EP2004/052382 WO2005030739A1 (en) 2003-09-30 2004-09-30 Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof

Publications (2)

Publication Number Publication Date
DE602004004674D1 DE602004004674D1 (de) 2007-03-22
DE602004004674T2 true DE602004004674T2 (de) 2007-11-22

Family

ID=34395298

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004004674T Expired - Lifetime DE602004004674T2 (de) 2003-09-30 2004-09-30 Verfahren zur herstellung von benzoxazolsulfonamidverbindungen und zwischenprodukten davon

Country Status (24)

Country Link
US (1) US20070123574A1 (https=)
EP (1) EP1670773B1 (https=)
JP (1) JP4919802B2 (https=)
KR (1) KR101090102B1 (https=)
CN (1) CN1860107B (https=)
AP (1) AP1985A (https=)
AT (1) ATE353323T1 (https=)
AU (1) AU2004276017B2 (https=)
BR (1) BRPI0414916A (https=)
CA (1) CA2537877C (https=)
DE (1) DE602004004674T2 (https=)
DK (1) DK1670773T3 (https=)
EA (1) EA011891B1 (https=)
ES (1) ES2281828T3 (https=)
IL (1) IL173891A0 (https=)
IN (1) IN2012DN02301A (https=)
MX (1) MXPA06003575A (https=)
NO (1) NO20061951L (https=)
NZ (1) NZ546279A (https=)
PL (1) PL1670773T3 (https=)
PT (1) PT1670773E (https=)
SI (1) SI1670773T1 (https=)
WO (1) WO2005030739A1 (https=)
ZA (1) ZA200602603B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR053845A1 (es) * 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
US8575186B2 (en) 2009-10-05 2013-11-05 Albany Molecular Research, Inc. Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof
AU2012207335A1 (en) 2011-01-19 2013-07-25 Albany Molecular Research, Inc. Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
WO2014194519A1 (en) 2013-06-07 2014-12-11 Merck Sharp & Dohme Corp. Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968942A (en) * 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
CN1530372A (zh) * 1995-03-10 2004-09-22 G.D.ɪ����˾ 杂环羰基氨基酸羟乙氨基磺酰胺逆转录病毒蛋白酶抑制剂
AU7722296A (en) * 1995-11-15 1997-06-05 G.D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
EP1208092B1 (en) * 2000-04-07 2006-06-21 Samsung Electronics Co., Ltd. Sulfonamide derivative as a matrix metalloproteinase inhibitor
US6455738B1 (en) * 2000-07-13 2002-09-24 Rhodia Chimie Process for the sulfonation of an aromatic compound
ES2275866T3 (es) * 2001-02-14 2007-06-16 Tibotec Pharmaceuticals Ltd. 2-(aminosustituido)-benzotiazol-sulfonamidas de amplio esprecto inhibidoras de la proteasa de vih.
EA009590B1 (ru) * 2001-05-11 2008-02-28 Тиботек Фармасьютикалз Лтд. 2-аминобензоксазолсульфонамидные ингибиторы вич-протеазы широкого спектра
TWI286476B (en) * 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors
MY142238A (en) * 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors

Also Published As

Publication number Publication date
EP1670773A1 (en) 2006-06-21
CN1860107B (zh) 2013-08-21
AU2004276017A1 (en) 2005-04-07
PT1670773E (pt) 2007-05-31
CA2537877C (en) 2015-03-17
DE602004004674D1 (de) 2007-03-22
AU2004276017B2 (en) 2010-08-19
NZ546279A (en) 2008-09-26
KR101090102B1 (ko) 2011-12-07
EA011891B1 (ru) 2009-06-30
ZA200602603B (en) 2008-05-28
IL173891A0 (en) 2006-07-05
ES2281828T3 (es) 2007-10-01
JP4919802B2 (ja) 2012-04-18
EA200600699A1 (ru) 2006-08-25
BRPI0414916A (pt) 2006-11-07
MXPA06003575A (es) 2006-06-05
CA2537877A1 (en) 2005-04-07
AP1985A (en) 2009-03-30
WO2005030739A1 (en) 2005-04-07
AP2006003603A0 (en) 2006-04-30
JP2007507468A (ja) 2007-03-29
NO20061951L (no) 2006-05-02
CN1860107A (zh) 2006-11-08
IN2012DN02301A (https=) 2015-08-14
SI1670773T1 (sl) 2007-06-30
EP1670773B1 (en) 2007-02-07
KR20060092224A (ko) 2006-08-22
PL1670773T3 (pl) 2007-06-29
DK1670773T3 (da) 2007-05-29
ATE353323T1 (de) 2007-02-15
US20070123574A1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
JP4818124B2 (ja) (3R,3aS,6aR)−ヘキサヒドロフロ〔2,3−b〕フラン−3−イル(1S,1R)−3−〔〔(4−アミノフェニル)スルホニル〕(イソブチル)アミノ〕−1−ベンジル−2−ヒドロキシプロピルカルバマートの製造方法
DE69332770T2 (de) Sulfonylalkanoylaminohydroxyethylaminosulfamidsäuren verwendbar als retrovirale Proteasehemmer
RU2376308C2 (ru) СПОСОБ ПОЛУЧЕНИЯ (3R, 3aS,6aR)-ГЕКСАГИДРОФУРО[2,3-b]ФУРАН-3-ИЛ(1S,2R)-3-[[(4-АМИНОФЕНИЛ)СУЛЬФОНИЛ](ИЗОБУТИЛ)АМИНО]-1-БЕНЗИЛ-2-ГИДРОКСИПРОПИЛКАРБАМАТА
DE60215623T2 (de) Breitspektrum 2-(substituierte-amino)-benzothiazol-sulfonamide hiv protease inhibitoren
JP5498497B2 (ja) (1S,2R)−3−[[(4−アミノフェニル)スルホニル](イソブチル)アミノ]−1−ベンジル−2−ヒドロキシプロピルカルバミン酸(3R,3aS,6aR)−ヘキサヒドロフロ[2,3−b]フラン−3−イルの製造方法
DE602004004674T2 (de) Verfahren zur herstellung von benzoxazolsulfonamidverbindungen und zwischenprodukten davon
DE60315984T2 (de) Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition